Skip to content

EVO PHARMA

Absorbed by New Familia KBO/BCE: BE 0885.020.377
EVO PHARMA
Follow Report

Mandates through the years

3 names

Board

Board

Statutory auditor
Earliermandate already running before its first mentionend not dated
Mandates as a list
    • Board, appointed by deed of 16-08-2017, last mentioned in 2017
    • Board, until 30-06-2017
    • Statutory auditor, appointed by deed of 12-07-2016, until 12-07-2016

Control

Shareholder in 2019
100%
This company
EVO PHARMA
Equity €122,676
Profit €388,283 in 2019

Capital

Capital
€18,600
Source
2019 annual accounts

Owners through the years

as the annual accounts name them
100%
100%
0.54%
0.54%
Owners as a list
    • 2014 to 2019: 100%
    • 2015 to 2019: 0.54%

Source: lists of holdings in the owners' accounts

Office holders in the KBO →

Next steps

See who ran this company and where its registered office was, on a date of your choice.Company as of a date See what became of the directors' other companies.Supplier due diligence

We would like to set cookies. That happens only with your consent. What we measure